Third-generation beta-blockers in the treatment of cardiovascular diseases

dc.contributor.advisorSzentmiklósi, József András
dc.contributor.advisordeptDepartment of Pharmacology and Pharmacotherapyhu_HU
dc.contributor.authorBrynleifsson, Magnús Ari
dc.contributor.departmentDE--Általános Orvostudományi Karhu_HU
dc.contributor.opponentDrimba, László
dc.contributor.opponentPórszász, Róbert
dc.contributor.opponentdeptKenézy Kórház, Aneszteziológiai és Intenziv Therápiás Osztályhu_HU
dc.contributor.opponentdeptDebreceni Egyetem::Általános Orvostudományi Kar::Farmakológiai és Farmakoterápiai Intézethu_HU
dc.date.accessioned2022-01-19T11:09:00Z
dc.date.available2022-01-19T11:09:00Z
dc.date.created2021-09
dc.description.abstractOverview of the pharmacology, and use of third-generation beta-blockers in the treatment of cardiovascular diseases, and a comparison between third-generation beta-blockers and older generations in the treatment of cardiovascular diseases. The third-generation beta-blockers have an additional vasodilatory effect that is not seen in the 1st- or 2nd-generations as well as other properties that might give them an advantage in the treatment of cardiovascular diseases in certain patient groups.hu_HU
dc.description.courseáltalános orvoshu_HU
dc.description.courselangangolhu_HU
dc.description.degreeegységes, osztatlanhu_HU
dc.format.extent39hu_HU
dc.identifier.urihttp://hdl.handle.net/2437/328024
dc.language.isoenhu_HU
dc.subjectThird-generation beta-blockershu_HU
dc.subjectCarvedilolhu_HU
dc.subjectNebivololhu_HU
dc.subjectLabetalolhu_HU
dc.subject.dspaceDEENK Témalista::Orvostudományhu_HU
dc.titleThird-generation beta-blockers in the treatment of cardiovascular diseaseshu_HU
Fájlok